Literature DB >> 11741885

Apical sorting of beta-secretase limits amyloid beta-peptide production.

Anja Capell1, Liane Meyn, Regina Fluhrer, David B Teplow, Jochen Walter, Christian Haass.   

Abstract

Polarized cells such as neurons and endothelial cells appear to be involved in two invariant pathological features of Alzheimer's disease pathology, namely the formation of senile plaques and cerebral amyloid angiopathy. This implicates polarized sorting mechanisms in the production and accumulation of amyloid beta-peptide (Abeta). We have now studied polarized sorting of beta-secretase (BACE) in Madin-Darby canine kidney (MDCK) cells. The majority of BACE is sorted to the apical surface of MDCK cells where very little beta-amyloid precursor protein (betaAPP) is observed, because betaAPP undergoes basolateral sorting. Consistent with the usage of similar mechanisms for polarized sorting, BACE was also found to be targeted to axons of hippocampal neurons. The remaining basolaterally sorted BACE competes with the highly polarized basolateral alpha-secretase activity. Therefore, substantial amounts of BACE are targeted away from betaAPP to a non-amyloidogenic compartment, a cellular mechanism that limits Abeta generation. In addition, no alpha-secretase activity was observed on the apical side whereas gamma-secretase activity is observed on the basolateral and the apical side. Consistent with this finding, substantial amounts of Abeta can be produced apically upon missorting of betaAPP to the apical surface. These data demonstrate that Abeta production is limited in polarized cells by differential targeting of BACE and its substrate betaAPP. Moreover, our findings suggest that betaAPP may not be a major physiological substrate of BACE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741885     DOI: 10.1074/jbc.M109119200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  BACE2 expression increases in human neurodegenerative disease.

Authors:  Christopher J Holler; Robin L Webb; Ashley L Laux; Tina L Beckett; Dana M Niedowicz; Rachel R Ahmed; Yinxing Liu; Christopher R Simmons; Amy L S Dowling; Angela Spinelli; Moshe Khurgel; Steven Estus; Elizabeth Head; Louis B Hersh; M Paul Murphy
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 2.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.

Authors:  Silke Brunholz; Sangram Sisodia; Alfredo Lorenzo; Carole Deyts; Stefan Kins; Gerardo Morfini
Journal:  Exp Brain Res       Date:  2011-09-30       Impact factor: 1.972

Review 3.  Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

Authors:  Scott A Small; Sam Gandy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 4.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 5.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

6.  Differential release of β-amyloid from dendrite- versus axon-targeted APP.

Authors:  Scott R DeBoer; Georgia Dolios; Rong Wang; Sangram S Sisodia
Journal:  J Neurosci       Date:  2014-09-10       Impact factor: 6.167

7.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

8.  Alzheimer's disease beta-amyloid peptides are released in association with exosomes.

Authors:  Lawrence Rajendran; Masanori Honsho; Tobias R Zahn; Patrick Keller; Kathrin D Geiger; Paul Verkade; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-12       Impact factor: 11.205

Review 9.  Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptors.

Authors:  Bor Luen Tang
Journal:  Cell Adh Migr       Date:  2009-01-21       Impact factor: 3.405

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.